View in EDS HTML Full Text PDF Full Text

Neutrophil-to-lymphocyte ratio half reduction as a surrogate of molecular response in polycythemia vera treated with ropeginterferon alfa-2b.

Saved in:
Bibliographic Details
Title: Neutrophil-to-lymphocyte ratio half reduction as a surrogate of molecular response in polycythemia vera treated with ropeginterferon alfa-2b.
Authors: Yoon SY; Division of Hematology and Medical Oncology, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea., Yoon SS; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea., Yang DH; Department of Internal Medicine, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Jeollanam-do, Korea., Lee GW; Division of Hematology-Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Korea., Sohn SK; Department of Hematology/Oncology, Kyungpook National University Hospital, Daegu, Korea., Shin HJ; Department of Hematology/Oncology, Pusan National University Hospital, Busan, Korea., Bae SH; Division of Hematology/Oncology, Department of Internal Medicine, Daegu Catholic, University Hospital, Daegu Catholic University School of Medicine, Daegu, Korea., Choi CW; Division of Oncology and Hematology, Department of Internal Medicine, Korea University Medical Center, Seoul, Korea., Choi EJ; Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea., Cheong JW; Division of Hematology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea., Bang SM; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea., Park JS; Departments of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea., Park Y; Division of Hematology-Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea., Park YH; Division of Hematology-Oncology, Department of Internal Medicine, Ewha Womans University Mokdong Hospital, Seoul, Korea., Lee SE; Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591, Korea.
Source: Therapeutic advances in hematology [Ther Adv Hematol] 2026 Mar 30; Vol. 17, pp. 20406207261431904. Date of Electronic Publication: 2026 Mar 30 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101549589 Publication Model: eCollection Cited Medium: Print ISSN: 2040-6207 (Print) Linking ISSN: 20406207 NLM ISO Abbreviation: Ther Adv Hematol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41924392
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Neutrophil-to-lymphocyte ratio half reduction as a surrogate of molecular response in polycythemia vera treated with ropeginterferon alfa-2b.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Yoon+SY%22">Yoon SY</searchLink>; Division of Hematology and Medical Oncology, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Yoon+SS%22">Yoon SS</searchLink>; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Yang+DH%22">Yang DH</searchLink>; Department of Internal Medicine, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Jeollanam-do, Korea.<br /><searchLink fieldCode="AU" term="%22Lee+GW%22">Lee GW</searchLink>; Division of Hematology-Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Korea.<br /><searchLink fieldCode="AU" term="%22Sohn+SK%22">Sohn SK</searchLink>; Department of Hematology/Oncology, Kyungpook National University Hospital, Daegu, Korea.<br /><searchLink fieldCode="AU" term="%22Shin+HJ%22">Shin HJ</searchLink>; Department of Hematology/Oncology, Pusan National University Hospital, Busan, Korea.<br /><searchLink fieldCode="AU" term="%22Bae+SH%22">Bae SH</searchLink>; Division of Hematology/Oncology, Department of Internal Medicine, Daegu Catholic, University Hospital, Daegu Catholic University School of Medicine, Daegu, Korea.<br /><searchLink fieldCode="AU" term="%22Choi+CW%22">Choi CW</searchLink>; Division of Oncology and Hematology, Department of Internal Medicine, Korea University Medical Center, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Choi+EJ%22">Choi EJ</searchLink>; Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Cheong+JW%22">Cheong JW</searchLink>; Division of Hematology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Bang+SM%22">Bang SM</searchLink>; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.<br /><searchLink fieldCode="AU" term="%22Park+JS%22">Park JS</searchLink>; Departments of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea.<br /><searchLink fieldCode="AU" term="%22Park+Y%22">Park Y</searchLink>; Division of Hematology-Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Park+YH%22">Park YH</searchLink>; Division of Hematology-Oncology, Department of Internal Medicine, Ewha Womans University Mokdong Hospital, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Lee+SE%22">Lee SE</searchLink>; Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591, Korea.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101549589%22">Therapeutic advances in hematology</searchLink> [Ther Adv Hematol] 2026 Mar 30; Vol. 17, pp. 20406207261431904. <i>Date of Electronic Publication: </i>2026 Mar 30 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage%22">Sage </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101549589 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2040-6207 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220406207%22">20406207 </searchLink><i>NLM ISO Abbreviation: </i>Ther Adv Hematol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41924392
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/20406207261431904
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 20406207261431904
    Titles:
      – TitleFull: Neutrophil-to-lymphocyte ratio half reduction as a surrogate of molecular response in polycythemia vera treated with ropeginterferon alfa-2b.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yoon SY
      – PersonEntity:
          Name:
            NameFull: Yoon SS
      – PersonEntity:
          Name:
            NameFull: Yang DH
      – PersonEntity:
          Name:
            NameFull: Lee GW
      – PersonEntity:
          Name:
            NameFull: Sohn SK
      – PersonEntity:
          Name:
            NameFull: Shin HJ
      – PersonEntity:
          Name:
            NameFull: Bae SH
      – PersonEntity:
          Name:
            NameFull: Choi CW
      – PersonEntity:
          Name:
            NameFull: Choi EJ
      – PersonEntity:
          Name:
            NameFull: Cheong JW
      – PersonEntity:
          Name:
            NameFull: Bang SM
      – PersonEntity:
          Name:
            NameFull: Park JS
      – PersonEntity:
          Name:
            NameFull: Park Y
      – PersonEntity:
          Name:
            NameFull: Park YH
      – PersonEntity:
          Name:
            NameFull: Lee SE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 03
              Text: 2026 Mar 30
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2040-6207
          Numbering:
            – Type: volume
              Value: 17
          Titles:
            – TitleFull: Therapeutic advances in hematology
              Type: main
ResultId 1